Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge

Published:2018-01-23 Issue:2 Volume:14 Page:137-153
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Zettl Uwe Klaus¹,Hecker Michael¹,Aktas Orhan²,Wagner Torsten³,Rommer Paulus S.⁴

Affiliation:

1. Department of Neurology, Neuroimmunology Section, University of Rostock, Rostock, Germany

2. Department of Neurology, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany

3. Department of Medical Affairs, Merck KGaA, Darmstadt, Germany

4. Department of Neurology, Medical University of Vienna, Vienna, Austria

Funder

Merck KGaA

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2018.1426462

Reference107 articles.

1. Defining the clinical course of multiple sclerosis: The 2013 revisions

2. Immune-mediated CNS diseases: A review on nosological classification and clinical features

3. Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial

4. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

5. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry;Therapeutic Advances in Neurological Disorders;2024-01

2. Interferon-beta-1a induced retinopathy in a 14-year-old female patient with multiple sclerosis;Neuroimmunology Reports;2024

3. Targeted Therapy for Neurological Disorders Using Nanomaterial-Based Drug Delivery Vehicle;Smart Nanomaterials Technology;2024

4. Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation;Expert Review of Clinical Immunology;2023-09-11

5. Matrine Mediated Immune Protection in MS by Regulating Gut Microbiota and Production of SCFAs;Molecular Neurobiology;2023-08-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3